Cover Image
Market Research Report

Precision Medicine Software Market by Delivery Mode (On-premise, Cloud-based), Application (Oncology, Pharmacogenomics, CNS), End User (Healthcare Providers, Research, Academia, Pharma, Biotech) - Global Forecast to 2027

Published by Meticulous Market Research Pvt. Ltd. Product code 931062
Published Content info 120 Pages
Delivery time: 1-2 business days
Price
Back to Top
Precision Medicine Software Market by Delivery Mode (On-premise, Cloud-based), Application (Oncology, Pharmacogenomics, CNS), End User (Healthcare Providers, Research, Academia, Pharma, Biotech) - Global Forecast to 2027
Published: March 4, 2020 Content info: 120 Pages
Description

The precision medicine software market is expected to grow at a CAGR of 11.8% from 2019 to 2027 to reach $2.8 billion by 2027.

The growth in the precision medicine software market is mainly attributed to the factors such as paradigm shift in treatment, rising pressure to decrease healthcare costs, scientific & technological advances in the genomics field, and growing focus towards providing companion diagnostics & biomarkers for various therapeutic areas. Moreover, emerging countries and AI in precision medicine provides significant growth opportunities for players operating in the precision medicine software market.

The precision medicine software market study presents historical market data in terms of value (2017, and 2018), current data (2019), and forecasts for 2027 - by delivery mode, application, and end user. The study also evaluates industry competitors and analyzes the market at regional and country level.

On the basis of delivery mode, the on-premise segment accounted for the largest share of the overall precision medicine software market in 2019. However, the web & cloud-based delivery mode segment is expected to grow at the faster CAGR during the forecast period, owing to its benefits, such as on-demand self-serving, no maintenance cost, low storage & upfront cost, and excessive storage flexibility. In addition, the factors such as greater security in private clouds and automated updating features of web and cloud solutions are further expected to support the rapid growth of this segment.

Based on application, the oncology segment accounted for the largest share of the overall precision medicine software market in 2019. However, the pharmacogenomics segment is expected to witness rapid growth during the forecast period. The factors such as increasing incidence of adverse drug reaction, growing focus on genomic-based study, shift from one-size-fits-all approach to personalized approach, and rising pressure on pharmaceutical companies to develop new drugs promote the fastest growth of this segment.

Based on end user, the healthcare providers segment commanded the largest share of the overall precision medicine software market in 2019. However, the pharmaceutical & biotechnological companies segment is expected to witness rapid growth during the forecast period. The factors such as increasing R&D activities related to precision medicine, increasing collaboration between pharma & biotech companies and software vendors, shift from conventional "one-size-fits-all-type" treatment to precision treatment, and rising R&D costs are the major factors driving rapid growth of this segment.

An in-depth analysis of the geographical scenario of the precision medicine software market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America commanded the largest share of the global precision medicine software market in 2019, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The factors such as well-established healthcare system in the region, rising adoption of technologically advanced products for cancer diagnosis & treatment, growing HCIT investment, government initiatives supporting developments in precision medicine, growing availability of research funding, and higher accessibility to precision medicine software are responsible for the largest share of North America in the precision medicine software market.

The key players operating in the global precision medicine software market are Syapse, Inc. (U.S.), Fabric Genomics, Inc. (U.S.), SOPHiA GENETICS SA (Switzerland), Human Longevity, Inc. (U.S.), Sunquest Information Systems Inc. (U.S.), LifeOmic Health, LLC (U.S.), Translational Software Inc. (U.S.), N-of-One (U.S.), Gene42 Inc. (Canada), PierianDx (U.S.), Foundation Medicine, Inc. (U.S.), and 2bPrecise (U.S.), among others.

Scope of the Report:

Market by Delivery Mode

  • On-premise
  • Web & Cloud-based

Market by Application

  • Oncology
  • Pharmacogenomics
  • Other Applications

Market by End User

  • Healthcare Providers
  • Research & Government Institutes
  • Pharmaceutical & Biotechnology Companies

Market by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
  • Japan
  • China
  • India
  • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East and Africa
Table of Contents

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
      • 2.3.1.1. Bottom-Up Approach
      • 2.3.1.2. Top-Down Approach
      • 2.3.1.3. Growth Forecast
    • 2.3.2. Market Share Analysis
  • 2.4. Assumptions for the Study
  • 2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Introduction
  • 4.2. Drivers
    • 4.2.1. Paradigm Shift in Treatment
    • 4.2.2. Rising Pressure to Decrease Healthcare Costs
    • 4.2.3. Scientific & Technological Advances in the Genomics Field
    • 4.2.4. Growing Focus Towards Providing Companion Diagnostics (CDx) & Biomarkers
  • 4.3. Restraints
    • 4.3.1. Lack of Awareness about Precision Medicine Practices
    • 4.3.2. Fragmented Healthcare Systems in Developing Countries
  • 4.4. Opportunities
    • 4.4.1. Emerging Economies
    • 4.4.2. Artificial Intelligence in Precision Medicine
  • 4.5. Challenge
    • 4.5.1. Lack of Reimbursement for Genetic Testing & Precision Medicine

5. Global Precision Medicine Software Market, by Delivery Mode

  • 5.1. Introduction
  • 5.2. On-Premise
  • 5.3. Web & Cloud-Based

6. Global Precision Medicine Software Market, by Application

  • 6.1. Introduction
  • 6.2. Oncology
  • 6.3. Pharmacogenomics
  • 6.4. Other Applications

7. Global Precision Medicine Software Market, by End User

  • 7.1. Introduction
  • 7.2. Healthcare Providers
  • 7.3. Research and Government Institutes
  • 7.4. Pharmaceutical & Biotechnology Companies

8. Geographic Analysis

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Rest of Europe (RoE)
  • 8.4. Asia-Pacific
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Rest of Asia-Pacific (RoAPAC)
  • 8.5. Latin America
  • 8.6. Middle East and Africa

9. Competitive Landscape

  • 9.1. Introduction
  • 9.2. Key Growth Strategies
  • 9.3. Competitive Benchmarking

10. Company Profiles (Business Overview, Strategic Developments, Product and Service Offering, Financial Overview)

  • 10.1. 2bprecise LLC (A Part of Allscripts Healthcare Solutions Inc.)
  • 10.2. Pieriandx, Inc.
  • 10.3. Gene42, Inc.
  • 10.4. Foundation Medicine, Inc.
  • 10.5. N-Of-One, Inc. (A Part of Qiagen N.V.)
  • 10.6. Translational Software, Inc.
  • 10.7. Syapse, Inc.
  • 10.8. Fabric Genomics, Inc.
  • 10.9. Sophia Genetics SA
  • 10.10. Human Longevity, Inc.
  • 10.11. Sunquest Information Systems, Inc.
  • 10.12. Lifeomic Health, LLC

11. Appendix

  • 11.1. Questionnaire
  • 11.2. Available Customization

List of Tables

  • Table 1 Precision Medicine Software Market: Impact Analysis of Market Drivers (2019-2027)
  • Table 2 Precision Medicine Software Market: Impact Analysis of Market Restraints (2019-2027)
  • Table 3 Precision Medicine Software Market Size, by Delivery Mode, 2017-2027 ($ Million)
  • Table 4 On-Premise Precision Medicine Software Market Size, by Country, 2017-2027 ($ Million)
  • Table 5 Web and Cloud-Based Precision Medicine Software Market Size, by Country, 2017-2027 ($ Million)
  • Table 6 Precision Medicine Software Market Size, by Application, 2017-2027 ($ Million)
  • Table 7 Companies Offering Precision Medicine Software for Oncology
  • Table 8 Precision Medicine Software Market Size for Oncology, by Country, 2017-2027 ($ Million)
  • Table 9 Companies Offering Precision Software for Pharmacogenomics
  • Table 10 Precision Medicine Software Market Size for Pharmacogenomics, by Country, 2017-2027 ($ Million)
  • Table 11 Precision Medicine Software Market Size for Other Applications, by Country, 2017-2027 ($ Million)
  • Table 12 Precision Medicine Software Market Size, by End User, 2017-2027 ($ Million)
  • Table 13 Strategic Developments by Key Companies
  • Table 14 Precision Medicine Software Market Size for Healthcare Providers, by Country, 2017-2027 ($ Million)
  • Table 15 Recent Funding
  • Table 16 Precision Medicine Software Market Size for Research & Government Institutes, by Country, 2017-2027 ($ Million)
  • Table 17 Strategic Developments by Key Companies
  • Table 18 Precision Medicine Software Market Size for Pharmaceutical & Biotechnological Companies, by Country, 2017-2027 ($ Million)
  • Table 19 Precision Medicine Software Market Size, by Country/Region, 2017-2027 ($Million)
  • Table 20 North America: Precision Medicine Software Market Size, by Country, 2017-2027 ($Million)
  • Table 21 North America: Precision Medicine Software Market Size, by Delivery Mode, 2017-2027 ($Million)
  • Table 22 North America: Precision Medicine Software Market Size, by Application, 2017-2027 ($Million)
  • Table 23 North America: Precision Medicine Software Market Size, by End User, 2017-2027 ($Million)
  • Table 24 U.S.: Precision Medicine Software Market Size, by Delivery Mode, 2017-2027 ($Million)
  • Table 25 U.S.: Precision Medicine Software Market Size, by Application, 2017-2027 ($Million)
  • Table 26 U.S.: Precision Medicine Software Market Size, by End User, 2017-2027 ($Million)
  • Table 27 Canada: Precision Medicine Software Market Size, by Delivery Mode, 2017-2027 ($Million)
  • Table 28 Canada: Precision Medicine Software Market Size, by Application, 2017-2027 ($Million)
  • Table 29 Canada: Precision Medicine Software Market Size, by End User, 2017-2027 ($Million)
  • Table 30 Europe: Precision Medicine Software Market Size, by Country, 2017-2027 ($Million)
  • Table 31 Europe: Precision Medicine Software Market Size, by Delivery Mode, 2017-2027 ($Million)
  • Table 32 Europe: Precision Medicine Software Market Size, by Application, 2017-2027 ($Million)
  • Table 33 Europe: Precision Medicine Software Market Size, by End User, 2017-2027 ($Million)
  • Table 34 Germany: Precision Medicine Software Market Size, by Delivery Mode, 2017-2027 ($Million)
  • Table 35 Germany: Precision Medicine Software Market Size, by Application, 2017-2027 ($Million)
  • Table 36 Germany: Precision Medicine Software Market Size, by End User, 2017-2027 ($Million)
  • Table 37 France: Precision Medicine Software Market Size, by Delivery Mode, 2017-2027 ($Million)
  • Table 38 France: Precision Medicine Software Market Size, by Application, 2017-2027 ($Million)
  • Table 39 France: Precision Medicine Software Market Size, by End User, 2017-2027 ($Million)
  • Table 40 U.K.: Precision Medicine Software Market Size, by Delivery Mode, 2017-2027 ($Million)
  • Table 41 U.K.: Precision Medicine Software Market Size, by Application, 2017-2027 ($Million)
  • Table 42 U.K.: Precision Medicine Software Market Size, by End User, 2017-2027 ($Million)
  • Table 43 Italy: Precision Medicine Software Market Size, by Delivery Mode, 2017-2027 ($Million)
  • Table 44 Italy: Precision Medicine Software Market Size, by Application, 2017-2027 ($Million)
  • Table 45 Italy: Precision Medicine Software Market Size, by End User, 2017-2027 ($Million)
  • Table 46 Spain: Precision Medicine Software Market Size, by Delivery Mode, 2017-2027 ($Million)
  • Table 47 Spain: Precision Medicine Software Market Size, by Application, 2017-2027 ($Million)
  • Table 48 Spain: Precision Medicine Software Market Size, by End User, 2017-2027 ($Million)
  • Table 49 Rest of Europe: Precision Medicine Software Market Size, by Delivery Mode, 2017-2027 ($Million)
  • Table 50 Rest of Europe: Precision Medicine Software Market Size, by Application, 2017-2027 ($Million)
  • Table 51 Rest of Europe: Precision Medicine Software Market Size, by End User, 2017-2027 ($Million)
  • Table 52 Asia-Pacific: Precision Medicine Software Market Size, by Country, 2017-2027 ($ Million)
  • Table 53 Asia-Pacific: Precision Medicine Software Market Size, by Delivery Mode, 2017-2027 ($ Million)
  • Table 54 Asia-Pacific: Precision Medicine Software Market Size, by Application, 2017-2027 ($ Million)
  • Table 55 Asia-Pacific: Precision Medicine Software Market Size, by End User, 2017-2027 ($ Million)
  • Table 56 Japan: Precision Medicine Software Market Size, by Delivery Mode, 2017-2027 ($ Million)
  • Table 57 Japan: Precision Medicine Software Market Size, by Application, 2017-2027 ($ Million)
  • Table 58 Japan: Precision Medicine Software Market Size, by End User, 2017-2027 ($ Million)
  • Table 59 China: Precision Medicine Software Market Size, by Delivery Mode, 2017-2027 ($ Million)
  • Table 60 China: Precision Medicine Software Market Size, by Application, 2017-2027 ($ Million)
  • Table 61 China: Precision Medicine Software Market Size, by End User, 2017-2027 ($ Million)
  • Table 62 India: Precision Medicine Software Market Size, by Delivery Mode, 2017-2027 ($ Million)
  • Table 63 India: Precision Medicine Software Market Size, by Application, 2017-2027 ($ Million)
  • Table 64 India: Precision Medicine Software Market Size, by End User, 2017-2027 ($ Million)
  • Table 65 Rest of Asia-Pacific: Precision Medicine Software Market Size, by Delivery Mode, 2017-2027 ($ Million)
  • Table 66 Rest of Asia-Pacific: Precision Medicine Software Market Size, by Application, 2017-2027 ($ Million)
  • Table 67 Rest of Asia-Pacific: Precision Medicine Software Market Size, by End User, 2017-2027 ($ Million)
  • Table 68 Latin America: Precision Medicine Software Market Size, by Delivery Mode, 2017-2027 ($ Million)
  • Table 69 Latin America: Precision Medicine Software Market Size, by Application, 2017-2027 ($ Million)
  • Table 70 Latin America: Precision Medicine Software Market Size, by End User, 2017-2027 ($ Million)
  • Table 71 Middle East and Africa: Precision Medicine Software Market Size, by Delivery Mode, 2017-2027 ($ Million)
  • Table 72 Middle East and Africa: Precision Medicine Software Market Size, by Application, 2017-2027 ($ Million)
  • Table 73 Middle East and Africa: Precision Medicine Software Market Size, by End User, 2017-2027 ($ Million)
  • Table 74 Recent Developments, by Company, 2016-2020 

List of Figures

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
  • Figure 6 Market Size Estimation
  • Figure 7 Global Precision Medicine Software Market, by Delivery Mode, 2019 Vs. 2027 ($Million)
  • Figure 8 Global Precision Medicine Software Market Size, by Application, 2019 Vs. 2027 ($Million)
  • Figure 9 Healthcare Providers to Dominate the Precision Medicine Software Market, by End User (2019-2027)
  • Figure 10 Precision Medicine Software Market, by Region
  • Figure 11 Market Dynamics
  • Figure 12 Paradigm Shift in Treatment from One-Size-Fit-All Medicine to Precision Medicine
  • Figure 13 Global Genomics Annual Funding ($Million)
  • Figure 14 Global Precision Medicine Software Market Size, by Delivery Mode 2019-2027 ($Million)
  • Figure 15 Global Precision Medicine Software Market Size, by Application, 2019-2027 ($Million)
  • Figure 16 Global Precision Medicine Software Market Size, by End User, 2019-2027 ($Million)
  • Figure 17 Global Precision Medicine Software Market Size, by Geography, 2019-2027 ($Million)
  • Figure 18 North America: Precision Medicine Software Market
  • Figure 19 North America: Precision Medicine Software Market Size, by Country, 2019-2027 ($Million)
  • Figure 20 Estimated Cancer Incidence in the U.S., 2000-2030 (Number of Cases)
  • Figure 21 Mortality from Cancer in the U.S., 2010-2030 (Number of Cases)
  • Figure 22 Share of Personalized Medicine in the Total Drugs Approved by FDA, 2014-2018 (%)

Figure 23] Europe: Precision Medicine Software Market Size, by Country, 2019-2027 ($Million)

  • Figure 24 Europe: Precision Medicine Software Market Size, by Country, 2019-2027 ($ Million)
  • Figure 25 Asia-Pacific: Precision Medicine Software Market
  • Figure 26 Asia Pacific: Precision Medicine Software Market Size, by Country, 2019 Vs 2027
  • Figure 27 Key Growth Strategies Adopted by Leading Players, 2016-2020
  • Figure 28 Precision Medicine Software Market: Competitive Benchmarking, by Application
  • Figure 29 Allscripts Healthcare Solutions Inc: Financial Overview (2019)
  • Figure 30 Qiagen N.V.: Financial Overview (2019)
  • Figure 31 Roper Technologies, Inc.: Financial Overview (2019)
Back to Top